Ligand Pharmaceuticals Inc (LGND)
Gross Profit Growth
35.24%
Quarterly · Period ending:
LGND Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported35.24%period ending
Latest reported35.24%period ending
LGND Quarterly Gross Profit YoY % (247.22% → 35.24%)
Year-over-year change
High-resolution chart · PNG
LGND gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 35.2393% | |
| 22.6336% | |
| 114.2702% | |
| 130.539% | |
| -21.3465% | |
| 103.335% | |
| 51.2085% | |
| 33.8087% | |
| 130.2182% | |
| -50.5489% | |
| 386.7796% | |
| -34.803% | |
| -34.6035% | |
| 26.5424% | |
| -91.0215% | |
| -15.5856% | |
| -30.1709% | |
| -32.2999% | |
| 3.842% | |
| 50.4127% | |
| 60.1196% | |
| 65.0291% | |
| 132.3905% | |
| 63.8659% | |
| 49.5705% | |
| -28.133% | |
| -55.7411% | |
| -50.9965% | |
| -74.601% | |
| -28.4329% | |
| 16.2316% | |
| 42.6363% | |
| 228.1744% | |
| 91.416% | |
| 38.077% | |
| 50.291% | |
| 44.0987% | |
| 0.812% | |
| 73.769% | |
| 25.3419% | |
| 18.8583% | |
| 112.1008% | |
| 6.9067% | |
| 22.0672% | |
| 67.8837% | |
| 0.1555% | |
| 41.5499% | |
| 28.757% | |
| 12.6225% | |
| 22.925% | |
| 18.6875% | |
| 83.8897% | |
| 57.6409% | |
| 100.4744% | |
| 3.9437% | |
| 12.9813% | |
| -9.1267% | |
| 62.5927% | |
| 176.0914% | |
| -35.4268% | |
| 0.0343% | |
| -43.4206% | |
| -86.5124% | |
| 206.3812% | |
| -23.1235% | |
| -37.0855% | |
| 135.7898% | |
| -239.7485% | |
| 58.0766% | |
| 94.2963% | |
| 114.714% | |
| -4.2161% | |
| 240.7092% | |
| 1,974.0426% | |
| -79.5796% | |
| -82.2726% | |
| -96.3071% | |
| -99.4298% | |
| -30.6771% | |
| -5.7052% | |
| 8.6787% | |
| 59.0123% | |
| 51.5298% | |
| -14.834% | |
| 15.0586% | |
| -6.7257% | |
| -45.0379% | |
| 69.4075% | |
| 42.9494% | |
| 68.3876% | |
| 124.4588% | |
| 15.79% | |
| 47.4629% | |
| -19.2059% | |
| 19.4282% | |
| 26.3443% | |
| -5.629% | |
| 34.9855% | |
| 218.4546% | |
| 11.2552% |